Shares of Moderna Inc.
slipped 5.21% to $161.91 Monday, on what proved to be an all-around dismal buying and selling session for the inventory market, with the NASDAQ Composite Index
falling 0.98% to 13,914.77 and Dow Jones Industrial Common
falling 0.36% to 34,077.63. Moderna Inc. closed $27.35 in need of its 52-week excessive ($189.26), which the corporate reached on February eighth.
The inventory underperformed when in comparison with a few of its opponents Monday, as AbbVie Inc.
rose 0.65% to $108.61, Amgen Inc.
rose 0.10% to $255.97, and AstraZeneca PLC ADR
rose 1.75% to $51.63. Buying and selling quantity (9.1 M) eclipsed its 50-day common quantity of 9.0 M.